PQ 321
321. Deputy Pat Casey asked the Minister for Health the way in which he has managed the risks associated with the use of valproate in pregnancy; the actions taken to minimise risk from 1990 when studies concluded clear evidence of risk of congenital abnormalities; and if he will make a statement on the matter. [26107/19]
Introduced
25 June 2019
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
25 June 2019
Summary
321. Deputy Pat Casey asked the Minister for Health the way in which he has managed the risks associated with the use of valproate in pregnancy; the actions taken to minimise risk from 1990 when studies concluded clear evidence of risk of congenital abnormalities; and if he will make a statement on the matter. [26107/19]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 25 June 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2019-06-25/321/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2019-06-25/pq_321